Velasmooth medical device for treatment of cellulite
Cellulite be gone
FDA clears cellulite treatment device developed by Israel-based Syneron
YOKNEAM - Syneron Medical Ltd. (NASDAQ: ELOS), a manufacturer and distributor of medical aesthetic devices, announced Monday the U.S. Food & Drug Administration (FDA) has granted pre-marketing clearance to the company’s VelaSmooth medical device for the temporary reduction in the appearance of cellulite.
The VelaSmooth also received clearance for the relief of minor muscle aches, pain and spasm and the temporary improvement of local blood circulation.
According to Dr. Tina Alster, director of the Washington Institute of Dermatologic Laser Surgery, VelaSmooth incorporates a combination of technologies enabling deeper heating and mechanical manipulation of cellulite in a non-invasive manner.
Syneron, which was founded in 2000 and currently employs some 120 workers, holds its research and development center in the northern Israeli town of Yokneam and headquarters in Toronto, Canada.
